D-1179-2023 Class III Terminated

Recalled by RB Health (US) LLC — Parsippany, NJ

FDA drug recall D-1179-2023 was initiated by RB Health (US) LLC on Aug 29, 2023 and is designated Class III. Reason for recall: Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging. The recall status is terminated (terminated Apr 22, 2025). Affected quantity: 6,072 cases/36,426 individual selling units.

Recall details

Product Type
Drugs
Report Date
Oct 4, 2023
Initiation Date
Aug 29, 2023
Termination Date
Apr 22, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,072 cases/36,426 individual selling units

Product description

Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%), packaged in 90-count plastic jar, further packaged in case of 6 jars per case, Distributed by RB Health (US), Parsippany, NJ 07054, NDC 63824-431-90

Reason for recall

Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging.

Distribution pattern

USA nationwide

Code information

Lot # KT220211, Exp 07/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1179-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1179-2023. Report a data issue: hello@regdatalab.com.